Ypsomed Holding Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Ypsomed Holding ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 0.53%.

Wichtige Informationen

0.5%

Dividendenausschüttung

0.004%

Rückkaufsrendite

Gesamte Aktionärsrendite	0.5%
Zukünftige Dividendenrendite	1.4%
Wachstum der Dividende	-1.4%
Nächster Dividendenzahlungstermin	n/a
Ex-Dividendendatum	n/a
Dividende pro Aktie	CHF 2.000
Ausschüttungsquote	35%

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Aug 13

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jul 31

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Jul 03

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Jun 19

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Jun 10

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

May 25

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

May 08

Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Apr 07

Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Mar 09

Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

Feb 07

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Jan 17

Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?

Dec 27

Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings

Nov 24

What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?

Oct 19

Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching

Jul 14

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Jun 20

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?

Feb 28

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: YPSN zahlt keine nennenswerte Dividende für den Markt Swiss, daher muss nicht geprüft werden, ob die Zahlungen stabil sind.

Wachsende Dividende: YPSN zahlt keine nennenswerte Dividende für den Markt Swiss, daher ist es nicht notwendig zu prüfen, ob die Zahlungen steigen.

Dividendenrendite im Vergleich zum Markt

Ypsomed Holding Dividendenrendite im Vergleich zum Markt

Wie sieht die Dividendenrendite von YPSN im Vergleich zum Markt aus?
Segment	Dividendenrendite
Unternehmen (YPSN)	0.5%
Untere 25 % des Marktes (CH)	2.0%
Markt Top 25 % (CH)	4.5%
Branchendurchschnitt (Medical Equipment)	0.7%
Analystenprognose (YPSN) (bis zu 3 Jahre)	1.4%

Bemerkenswerte Dividende: YPSNDie Dividende des Unternehmens (0.53%) ist im Vergleich zu den unteren 25 % der Dividendenzahler auf dem Markt Swiss (2%) nicht bemerkenswert.

Hohe Dividende: YPSNDie Dividende des Unternehmens (0.53%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt Swiss (4.46%) niedrig.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: YPSN zahlt keine nennenswerte Dividende für den Markt Swiss.

Barausschüttung an die Aktionäre

Cashflow-Deckung: YPSN zahlt eine Dividende, aber das Unternehmen hat keinen freien Cashflow.

Ypsomed Holding Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Updates zu Dividenden und Rückkäufen

Upcoming dividend of €1.30 per share at 0.5% yield

Upcoming dividend of CHF0.60 per share

Upcoming dividend of CHF1.16 per share

Recent updates

New minor risk - Share price stability

Ypsomed Group and CamDiab Receives Health Canada Approval for mylife YpsoPump and CamAPS FX and Provide an Enhancing Diabetes Management

Now 23% undervalued

Now 21% undervalued

Ypsomed Holding AG to Report First Half, 2025 Results on Nov 13, 2024

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

MTD Medical Technology and Devices S.A. completed the acquisition of the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG (SWX:YPSN).

MTD Medical Technology and Devices S.A. completed the acquisition of the Pen Needle and Blood Glucose Monitoring Businesses of Ypsomed Holding AG (SWX:YPSN).

There Are Reasons To Feel Uneasy About Ypsomed Holding's (VTX:YPSN) Returns On Capital

If EPS Growth Is Important To You, Ypsomed Holding (VTX:YPSN) Presents An Opportunity

Price target increased by 7.6% to CHF378

Here's Why Ypsomed Holding AG's (VTX:YPSN) CEO May Deserve A Raise

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF395?

Here's What Analysts Are Forecasting For Ypsomed Holding AG (VTX:YPSN) After Its Full-Year Results

Full year 2024 earnings released: EPS: CHF5.74 (vs CHF3.82 in FY 2023)

Investor sentiment improves as stock rises 17%

Ypsomed Holding AG to Report Q4, 2024 Results on May 22, 2024

Investors Appear Satisfied With Ypsomed Holding AG's (VTX:YPSN) Prospects

Price target increased by 14% to CHF365

Investors Could Be Concerned With Ypsomed Holding's (VTX:YPSN) Returns On Capital

Is There Now An Opportunity In Ypsomed Holding AG (VTX:YPSN)?

Here's Why We Think Ypsomed Holding (VTX:YPSN) Might Deserve Your Attention Today

We Think Ypsomed Holding (VTX:YPSN) Can Stay On Top Of Its Debt

Ypsomed Holding AG's (VTX:YPSN) Popularity With Investors Is Clear

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF298?

First half 2024 earnings released: EPS: CHF2.68 (vs CHF1.17 in 1H 2023)

Do Ypsomed Holding's (VTX:YPSN) Earnings Warrant Your Attention?

Price target increased by 14% to CHF315

Ypsomed Holding AG to Report First Half, 2024 Results on Nov 15, 2023

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Ypsomed Holding (VTX:YPSN) May Have Issues Allocating Its Capital

Should You Think About Buying Ypsomed Holding AG (VTX:YPSN) Now?

Ypsomed Holding AG, Annual General Meeting, Jun 26, 2024

Upcoming dividend of €1.30 per share at 0.5% yield

Should You Be Adding Ypsomed Holding (VTX:YPSN) To Your Watchlist Today?

Consensus EPS estimates increase by 15%

Ypsomed Holding (VTX:YPSN) Seems To Use Debt Quite Sensibly

Price target increased by 13% to CHF257

Ypsomed Holding AG to Report Fiscal Year 2023 Results on May 24, 2023

What Does Ypsomed Holding AG's (VTX:YPSN) Share Price Indicate?

Ypsomed Holding (VTX:YPSN) Could Be Struggling To Allocate Capital

Ypsomed Holding AG, Annual General Meeting, Jun 28, 2023

At CHF187, Is It Time To Put Ypsomed Holding AG (VTX:YPSN) On Your Watch List?

These 4 Measures Indicate That Ypsomed Holding (VTX:YPSN) Is Using Debt Reasonably Well

Price target increased to CHF223

Mediq B.V. completed the acquisition of DiaExpert GmbH from Ypsomed Holding AG (SWX:YPSN).

Is Now The Time To Put Ypsomed Holding (VTX:YPSN) On Your Watchlist?

Investor sentiment deteriorated over the past week

Now 21% undervalued

Investors Shouldn't Be Too Comfortable With Ypsomed Holding's (VTX:YPSN) Robust Earnings

Consensus forecasts updated

Price target increased to CHF207

First half 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

No independent directors

What Is Ypsomed Holding AG's (VTX:YPSN) Share Price Doing?

Price target decreased to CHF192

Why Ypsomed Holding AG (VTX:YPSN) Could Be Worth Watching

Upcoming dividend of CHF0.60 per share

Here's What's Concerning About Ypsomed Holding's (VTX:YPSN) Returns On Capital

Full year 2022 earnings: EPS in line with analyst expectations despite revenue beat

Ypsomed Holding AG to Report Fiscal Year 2022 Results on May 25, 2022

Price target increased to CHF218

No independent directors

Now 20% undervalued after recent price drop

Should You Investigate Ypsomed Holding AG (VTX:YPSN) At CHF161?

Now 21% undervalued

Consensus EPS estimates increase by 32%

Now 20% undervalued

Price target increased to CHF178

First half 2022 earnings released

Price target increased to CHF168